Tg(Ins1-Mir30d,-EGFP)LXtng
Transgene Detail
|
|
| Symbol: |
Tg(Ins1-Mir30d,-EGFP)LXtng |
| Name: |
transgene insertion L, Xiaoqing Tang |
| MGI ID: |
MGI:7450936 |
| Synonyms: |
TgL |
| Transgene: |
Tg(Ins1-Mir30d,-EGFP)LXtng Location: unknown
|
| Alliance: |
Tg(Ins1-Mir30d,-EGFP)LXtng page
|
|
| Strain of Origin: |
C57BL/6 x SJL
|
|
| Transgene Type: |
|
Transgenic (Inserted expressed sequence, Reporter) |
| Mutation: |
|
Insertion
|
| |
|
Tg(Ins1-Mir30d,-EGFP)LXtng expresses
1 gene
Transgene expresses:
| Organism |
Expressed Gene |
Note |
| mouse |
Mir30d (MGI:2676910) |
|
|
| |
|
Mutation details: The transgenic construct is designed to express murine microRNA-30d and EGFP under control of the mouse insulin I (Ins1) promoter. The Founde L mice have low transgene expression (2-fold) and 1 copy of the transgene,
(J:334482)
|
|
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 1 strain available
Cell Lines: 0 lines available
|
|
| Original: |
J:334482 Mao Y, et al., Transgenic overexpression of microRNA-30d in pancreatic beta-cells progressively regulates beta-cell function and identity. Sci Rep. 2022 Jul 13;12(1):11969 |
| All: |
1 reference(s) |
|